Albertsons Companies, INC 10-K annual reports
Annual reports — audited financials, the full risk-factor list, and management’s account of the year.
NYSE
Albertsons Companies, Inc. reports fiscal 2025 financial results, highlighting a 2.0% increase in identical sales and a $773.8 million charge related to an opioid settlement framework.
NYSE
Albertsons Companies, Inc. reports a 2.0% increase in identical sales for fiscal 2024, driven by pharmacy and digital growth, despite the termination of its merger agreement with Kroger.
NYSE
10-K: Albertsons Companies, Inc. Files 10-K Annual Report, Details Financial Performance and Risk Factors
Albertsons Companies, Inc. released its annual report on Form 10-K, providing a comprehensive overview of its business, financial results, and potential risks for the fiscal year ended February 24, 2024.